Maze Therapeutics, Inc. Share Price

Maze Therapeutics, Inc. Share Price

NASDAQ: MAZE | Small Cap
$32.31
+$0.50 (1.57%) Last updated on 29 Oct, 2026 | 20:38 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Maze Therapeutics, Inc. Stock Performance

Open
$31.56
Prev. Close
$31.81
Circuit Range
N/A
Day Range
$31.56 - $32.60
Year Range
$21.98 - $53.60
Volume
9,459
Average Traded
$32.37

Maze Therapeutics, Inc. Share Price Today

As of 29 October 2026, Maze Therapeutics, Inc.'s share price is $32.31. The stock opened at $31.56, compared to its previous close of $31.81. During today's trading session, Maze Therapeutics, Inc.'s share price traded between $31.56 and $32.60, with an average price of $32.08. Over the past 52 weeks, the stock has recorded a high of $53.60 and a low of $21.98. In terms of performance, Maze Therapeutics, Inc.'s share price has risen by 21.56% over the last six months and is down 1.67% on a year-on-year basis.

Maze Therapeutics, Inc. Share Price Chart

Line chart of the Maze Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 31.56 to 32.66, ending at 32.31.
$31.56$32.60
L
Show Current Price
H

Maze Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.39B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.40
Revenue (TTM)
$0.00
Return On Equity (TTM)
-29.48%
Profit Margin
N/A
Debt to Equity
0.09
Quarterly Earnings Growth YoY
-48.65%

Maze Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$20.00$0.00
Net Profit-$30.09-$34.57-$24.21-$44.73
Net Profit MarginN/AN/A-121.05%N/A
Income ChangeN/A-14.89%29.97%-84.76%

Maze Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$131.12
Net Profit MarginN/A
Income ChangeN/A

About Maze Therapeutics, Inc.

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.

Maze Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$27.14
$32.22
+18.48%
Sep 2026
$26.46
$27.20
-4.90%
Aug 2026
$26.00
$28.59
+6.22%
Jul 2026
$29.50
$26.92
-9.66%
Jun 2026
$25.82
$29.80
+12.71%
May 2026
$26.57
$26.44
-0.53%
Apr 2026
$30.89
$26.58
-10.72%
Mar 2026
$44.39
$29.77
-34.54%
Feb 2026
$43.59
$45.48
+4.29%
Jan 2026
$40.80
$43.61
+5.16%
Dec 2025
$37.44
$41.47
+9.78%
Nov 2025
$32.75
$37.77
+14.96%

MAZE Share Price FAQs